Skip to content
PILLARS
HomeRecent BillsActionsMore
ExploreElectionsPresidential ActionsPoliticiansTrending Bills
WatchlistSettingsProfile
HomeRecent BillsActionsMore
PILLARS

The bills, politicians, and elections that shape your life, in plain English.

Get the App
Our Receipts
Sources & MethodologyApp DetailsSend Feedback
The Legal Stuff
Privacy PolicyTerms of ServiceContact Us
Find Us On
© 2026 Political Pillars Inc.Simplifying politics
Requires Drug Price Disclosure in Ads
Recent Bills/Requires Drug Price Disclosure in Ads

Requires Drug Price Disclosure in Ads

IntroducedN/A
Introduced1 year ago
Intro
Senate
House
Pres
Read twice and referred to the Committee on Finance. (text: CR S337-338; Sponsor introductory remarks on measure: CR S337)
More:Recently Introduced BillsHealthcareSenate Bills
Why This Matters

This bill requires that advertisements for prescription drugs and biological products clearly show their prices. It aims to help consumers make informed choices about their medications.

If you watch drug advertisements, you will see clear pricing information, helping you understand what you might pay.
Who this affects
Consumers · High-deductible health plan holders
What changes is this bill making?
  1. 1This bill mandates that advertisements for prescription drugs include clear pricing information.
  2. 2Consumers will have better access to understand the costs of medications before making decisions.
  3. 3The legislation aims to reduce the influence of advertising on prescription choices by providing price transparency.
  4. 4Patients with high-deductible health plans will benefit from knowing the actual costs of drugs they may need.
Read the detailed summary

Drug-price Transparency for Consumers Act of 2025 or the DTC Act of 2025This bill requires consumer advertisements for prescription drugs and biological products to include certain price information if the drug or biologic is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law. Specifically, such advertisements must clearly and conspicuously disclose the wholesale price for a 30-day supply of the drug or biologic and may explain that a consumer may pay a different amount for the drug or biologic depending on the consumer's health insurance coverage. The requirement does not apply to advertisements for drugs or biologics with a wholesale cost of less than $35 for a one-month supply. Each violation of this requirement is subject to a civil penalty of not more than $100,000.

Last changed 25 days ago · checked hourly

Bill Progress1 of 4
Bills must pass the House, Senate, and be signed by the President to become law.
Intro
Senate
House
Pres
IntroducedCurrentJan 7, 2025

Read twice and referred to the Committee on Finance. (text: CR S337-338; Sponsor introductory remarks on measure: CR S337)

Sponsors
See all 10 sponsors
Senate
House
President

The President

Donald Trump
President
Awaiting Vote
Similar Bills
House Bill · HR 3789
1 of 4 · Introduced
Drug Price Transparency Bill
DTC Act of 2025
·Healthcare
Senate Bill · S 2355
1 of 4 · Introduced
Hospitals Must Disclose Prices Clearly
Patients Deserve Price Tags Act
·Healthcare
House Bill · HR 267
1 of 4 · Introduced
Requires Hospitals to Share Prices Clearly
Health Care PRICE Transparency Act
·Healthcare